Cargando…
Amlodipine and lufenuron as repurposing drugs against Sporothrix brasiliensis
BACKGROUND: Sporotrichosis caused by Sporothrix brasiliensis is a globally emerging infectious disease with limited therapeutic options. Thus, we aimed to evaluate the in vitro activity of amlodipine (AML) and lufenuron (LUF) alone and their interaction with itraconazole (ITZ), the first-choice drug...
Autores principales: | Poester, Vanice Rodrigues, Hidalgo, Jéssica Estefania Dávila, Jardim, Lara Severo, Trápaga, Mariana Rodrigues, Rabello, Vanessa Brito de Souza, Almeida-Paes, Rodrigo, Zancope-Oliveira, Rosely Maria, Xavier, Melissa Orzechowski |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693817/ https://www.ncbi.nlm.nih.gov/pubmed/38050607 http://dx.doi.org/10.7717/peerj.16443 |
Ejemplares similares
-
Sporothrix brasiliensis: Epidemiology, Therapy, and Recent Developments
por: Xavier, Melissa Orzechowski, et al.
Publicado: (2023) -
Tattooing as a gateway to Sporothrix brasiliensis infection
por: Poester, Vanice Rodrigues, et al.
Publicado: (2022) -
Treatment of Human Sporotrichosis Caused by Sporothrix brasiliensis
por: Poester, Vanice Rodrigues, et al.
Publicado: (2022) -
Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine
por: Almeida-Paes, Rodrigo, et al.
Publicado: (2016) -
Sporotrichosis Caused by Non-Wild Type Sporothrix brasiliensis Strains
por: Bernardes-Engemann, Andréa Reis, et al.
Publicado: (2022)